SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 2189377

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2189377

RNA Editing Market Size, Share & Trends Analysis Report By Offering, By Technology, By Delivery Modality, By Application, By End-use, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

RNA Editing Market Summary

The global RNA editing market size was valued at USD 157.9 million in 2025 and is projected to grow from USD 184.8 million in 2026 to USD 588.4 million by 2033, at a CAGR of 18.0% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 58.0% in 2025. The market growth is driven by rising partnership and licensing activity between large pharmaceutical companies and RNA editing developers, the first clinical evidence of therapeutic RNA editing in humans, and growing interest in reversible editing approaches that correct disease-causing mutations at the RNA level without permanently changing the genome.

Global RNA Editing Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global RNA editing market report based on offering, technology, delivery modality, application, end use, and region:

  • Offering Outlook (Revenue, USD Million, 2021 - 2033)
  • Therapeutics Development & Licensing
  • Research Tools & Reagents
  • Services
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • ADAR-mediated (A-to-I) Editing
  • APOBEC-mediated (C-to-U) Editing
  • Others (Exon Editing, Pseudouridylation)
  • Delivery Modality Outlook (Revenue, USD Million, 2021 - 2033)
  • Oligonucleotide-based
  • AAV-delivered
  • LNP-delivered
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Rare Genetic Disorders
  • Neurological Disorders
  • Oncology
  • Liver Diseases
  • Cardiometabolic Diseases
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • CROs & CDMOs
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
    • Kuwait
Product Code: GVR-4-68041-063-1

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Offering Segment
      • 1.1.1.2. Technology Segment
      • 1.1.1.3. Delivery Modality Segment
      • 1.1.1.4. Application Segment
      • 1.1.1.5. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis:
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
    • 1.9.2. List of Secondary Sources
    • 1.9.3. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing Pharma Partnerships and Licensing Deals
      • 3.2.1.2. Clinical Validation of Therapeutic RNA Editing in Humans
      • 3.2.1.3. Reversible and Safer Editing Compared with DNA Editing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Delivery Limitations and Variable Clinical Efficacy
      • 3.2.2.2. Limited Commercial Revenue Ahead of Product Approvals
    • 3.2.3. Market Opportunities Analysis
    • 3.2.4. Market Challenges Analysis
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Economic landscape
      • 3.3.2.5. Legal landscape
      • 3.3.2.6. Environmental landscape

Chapter 4. Offering Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. RNA Editing Market: Offering Movement Analysis
  • 4.3. Therapeutics Development & Licensing
    • 4.3.1. Therapeutics Development & Licensing Market, 2021 - 2033 (USD Million)
  • 4.4. Research Tools & Reagents
    • 4.4.1. Research Tools & Reagents Market, 2021 - 2033 (USD Million)
  • 4.5. Services
    • 4.5.1. Services Market, 2021 - 2033 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. RNA Editing Market: Technology Movement Analysis
  • 5.3. ADAR-mediated (A-to-I) Editing
    • 5.3.1. ADAR-mediated (A-to-I) Editing Market, 2021 - 2033 (USD Million)
  • 5.4. APOBEC-mediated (C-to-U) Editing
    • 5.4.1. APOBEC-mediated (C-to-U) Editing Market, 2021 - 2033 (USD Million)
  • 5.5. Others (Exon Editing, Pseudouridylation)
    • 5.5.1. Others (Exon Editing, Pseudouridylation) Market, 2021 - 2033 (USD Million)

Chapter 6. Delivery Modality Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. RNA Editing Market: Delivery Modality Movement Analysis
  • 6.3. Oligonucleotide-based
    • 6.3.1. Oligonucleotide-based Market, 2021 - 2033 (USD Million)
  • 6.4. AAV-delivered
    • 6.4.1. AAV-delivered Market, 2021 - 2033 (USD Million)
  • 6.5. LNP-delivered
    • 6.5.1. LNP-delivered Market, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. Application Business Analysis

  • 7.1. Segment Dashboard
  • 7.2. RNA Editing Market: Application Movement Analysis
  • 7.3. Rare Genetic Disorders
    • 7.3.1. Rare Genetic Disorders Market, 2021 - 2033 (USD Million)
  • 7.4. Neurological Disorders
    • 7.4.1. Neurological Disorders Market, 2021 - 2033 (USD Million)
  • 7.5. Oncology
    • 7.5.1. Oncology Market, 2021 - 2033 (USD Million)
  • 7.6. Liver Diseases
    • 7.6.1. Liver Diseases Market, 2021 - 2033 (USD Million)
  • 7.7. Cardiometabolic Diseases
    • 7.7.1. Cardiometabolic Diseases Market, 2021 - 2033 (USD Million)
  • 7.8. Others
    • 7.8.1. Others Market, 2021 - 2033 (USD Million)

Chapter 8. End Use Business Analysis

  • 8.1. Segment Dashboard
  • 8.2. RNA Editing Market: End Use Movement Analysis
  • 8.3. Pharmaceutical & Biotechnology Companies
    • 8.3.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Million)
  • 8.4. Academic & Research Institutes
    • 8.4.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)
  • 8.5. CROs & CDMOs
    • 8.5.1. CROs & CDMOs Market, 2021 - 2033 (USD Million)

Chapter 9. Regional Business Analysis

  • 9.1. RNA Editing Market Share By Region, 2025 & 2033
  • 9.2. North America
    • 9.2.1. North America RNA Editing Market, 2021 - 2033 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Competitive Scenario
      • 9.2.2.3. Regulatory Framework
      • 9.2.2.4. U.S. RNA Editing Market, 2021 - 2033 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Competitive Scenario
      • 9.2.3.3. Regulatory Framework
      • 9.2.3.4. Canada RNA Editing Market, 2021 - 2033 (USD Million)
    • 9.2.4. Mexico
      • 9.2.4.1. Key Country Dynamics
      • 9.2.4.2. Competitive Scenario
      • 9.2.4.3. Regulatory Framework
      • 9.2.4.4. Mexico RNA Editing Market, 2021 - 2033 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe RNA Editing Market, 2021 - 2033 (USD Million)
    • 9.3.2. Germany
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Competitive Scenario
      • 9.3.2.3. Regulatory Framework
      • 9.3.2.4. Germany RNA Editing Market, 2021 - 2033 (USD Million)
    • 9.3.3. UK
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Competitive Scenario
      • 9.3.3.3. Regulatory Framework
      • 9.3.3.4. UK RNA Editing Market, 2021 - 2033 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Competitive Scenario
      • 9.3.4.3. Regulatory Framework
      • 9.3.4.4. France RNA Editing Market, 2021 - 2033 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Competitive Scenario
      • 9.3.5.3. Regulatory Framework
      • 9.3.5.4. Italy RNA Editing Market, 2021 - 2033 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Competitive Scenario
      • 9.3.6.3. Regulatory Framework
      • 9.3.6.4. Spain RNA Editing Market, 2021 - 2033 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Competitive Scenario
      • 9.3.7.3. Regulatory Framework
      • 9.3.7.4. Denmark RNA Editing Market, 2021 - 2033 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Competitive Scenario
      • 9.3.8.3. Regulatory Framework
      • 9.3.8.4. Sweden RNA Editing Market, 2021 - 2033 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Competitive Scenario
      • 9.3.9.3. Regulatory Framework
      • 9.3.9.4. Norway RNA Editing Market, 2021 - 2033 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific RNA Editing Market, 2021 - 2033 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competitive Scenario
      • 9.4.2.3. Regulatory Framework
      • 9.4.2.4. Japan RNA Editing Market, 2021 - 2033 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competitive Scenario
      • 9.4.3.3. Regulatory Framework
      • 9.4.3.4. China RNA Editing Market, 2021 - 2033 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competitive Scenario
      • 9.4.4.3. Regulatory Framework
      • 9.4.4.4. India RNA Editing Market, 2021 - 2033 (USD Million)
    • 9.4.5. Australia
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Competitive Scenario
      • 9.4.5.3. Regulatory Framework
      • 9.4.5.4. Australia RNA Editing Market, 2021 - 2033 (USD Million)
    • 9.4.6. South Korea
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Competitive Scenario
      • 9.4.6.3. Regulatory Framework
      • 9.4.6.4. South Korea RNA Editing Market, 2021 - 2033 (USD Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Competitive Scenario
      • 9.4.7.3. Regulatory Framework
      • 9.4.7.4. Thailand RNA Editing Market, 2021 - 2033 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America RNA Editing Market, 2021 - 2033 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. Regulatory Framework
      • 9.5.2.4. Brazil RNA Editing Market, 2021 - 2033 (USD Million)
    • 9.5.3. Argentina
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Regulatory Framework
      • 9.5.3.4. Argentina RNA Editing Market, 2021 - 2033 (USD Million)
  • 9.6. MEA
    • 9.6.1. MEA RNA Editing Market, 2021 - 2033 (USD Million)
    • 9.6.2. Saudi Arabia
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Regulatory Framework
      • 9.6.2.4. Saudi Arabia RNA Editing Market, 2021 - 2033 (USD Million)
    • 9.6.3. South Africa
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. Regulatory Framework
      • 9.6.3.4. South Africa RNA Editing Market, 2021 - 2033 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Competitive Scenario
      • 9.6.4.3. Regulatory Framework
      • 9.6.4.4. UAE RNA Editing Market, 2021 - 2033 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Competitive Scenario
      • 9.6.5.3. Regulatory Framework
      • 9.6.5.4. Kuwait RNA Editing Market, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Company Market Share/ Position Analysis, 2025
  • 10.3. Strategy Mapping
  • 10.4. Company Profiles/Listing
    • 10.4.1. Wave Life Sciences Ltd.
      • 10.4.1.1. Overview
      • 10.4.1.2. Financial Performance
      • 10.4.1.3. Product Type Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. ProQR Therapeutics N.V.
      • 10.4.2.1. Overview
      • 10.4.2.2. Financial Performance
      • 10.4.2.3. Product Type Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. Korro Bio Inc.
      • 10.4.3.1. Overview
      • 10.4.3.2. Financial Performance
      • 10.4.3.3. Product Type Benchmarking
      • 10.4.3.4. Strategic Initiatives
    • 10.4.4. Ascidian Therapeutics
      • 10.4.4.1. Overview
      • 10.4.4.2. Financial Performance
      • 10.4.4.3. Product Type Benchmarking
      • 10.4.4.4. Strategic Initiatives
    • 10.4.5. Shape Therapeutics
      • 10.4.5.1. Overview
      • 10.4.5.2. Financial Performance
      • 10.4.5.3. Product Type Benchmarking
      • 10.4.5.4. Strategic Initiatives
    • 10.4.6. AIRNA
      • 10.4.6.1. Overview
      • 10.4.6.2. Financial Performance
      • 10.4.6.3. Product Type Benchmarking
      • 10.4.6.4. Strategic Initiatives
    • 10.4.7. ADARx Pharmaceuticals
      • 10.4.7.1. Overview
      • 10.4.7.2. Financial Performance
      • 10.4.7.3. Product Type Benchmarking
      • 10.4.7.4. Strategic Initiatives
    • 10.4.8. Rznomics Inc.
      • 10.4.8.1. Overview
      • 10.4.8.2. Financial Performance
      • 10.4.8.3. Product Type Benchmarking
      • 10.4.8.4. Strategic Initiatives
    • 10.4.9. Amber Bio
      • 10.4.9.1. Overview
      • 10.4.9.2. Financial Performance
      • 10.4.9.3. Product Type Benchmarking
      • 10.4.9.4. Strategic Initiatives
Product Code: GVR-4-68041-063-1

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 4 Global RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 5 Global RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 6 Global RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 7 Global RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 8 Global RNA editing market, by region, 2021 - 2033 (USD Million)
  • Table 9 North America RNA editing market, by country, 2021 - 2033 (USD Million)
  • Table 10 North America RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 11 North America RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 12 North America RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 13 North America RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 14 North America RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 15 U.S. RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 16 U.S. RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 17 U.S. RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 18 U.S. RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 19 U.S. RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Canada RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 21 Canada RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 22 Canada RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 23 Canada RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 24 Canada RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 25 Mexico RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 26 Mexico RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 27 Mexico RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 28 Mexico RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 29 Mexico RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 30 Europe RNA editing market, by country, 2021 - 2033 (USD Million)
  • Table 31 Europe RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 32 Europe RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 33 Europe RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 34 Europe RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 35 Europe RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 36 Germany RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 37 Germany RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 38 Germany RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 39 Germany RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 40 Germany RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 41 UK RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 42 UK RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 43 UK RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 44 UK RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 45 UK RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 46 France RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 47 France RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 48 France RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 49 France RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 50 France RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 51 Italy RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 52 Italy RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 53 Italy RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 54 Italy RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 55 Italy RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 56 Spain RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 57 Spain RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 58 Spain RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 59 Spain RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 60 Spain RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 61 Denmark RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 62 Denmark RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 63 Denmark RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 64 Denmark RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 65 Denmark RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 66 Sweden RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 67 Sweden RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 68 Sweden RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 69 Sweden RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 70 Sweden RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 71 Norway RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 72 Norway RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 73 Norway RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 74 Norway RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 75 Norway RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 76 Asia Pacific RNA editing market, by country, 2021 - 2033 (USD Million)
  • Table 77 Asia Pacific RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 78 Asia Pacific RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 79 Asia Pacific RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 80 Asia Pacific RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 81 Asia Pacific RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 82 Japan RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 83 Japan RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 84 Japan RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 85 Japan RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 86 Japan RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 87 China RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 88 China RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 89 China RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 90 China RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 91 China RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 92 India RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 93 India RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 94 India RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 95 India RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 96 India RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 97 Australia RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 98 Australia RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 99 Australia RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 100 Australia RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 101 Australia RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 102 South Korea RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 103 South Korea RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 104 South Korea RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 105 South Korea RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 106 South Korea RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 107 Thailand RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 108 Thailand RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 109 Thailand RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 110 Thailand RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 111 Thailand RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 112 Latin America RNA editing market, by country, 2021 - 2033 (USD Million)
  • Table 113 Latin America RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 114 Latin America RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 115 Latin America RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 116 Latin America RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 117 Latin America RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 118 Brazil RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 119 Brazil RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 120 Brazil RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 121 Brazil RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 122 Brazil RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 123 Argentina RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 124 Argentina RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 125 Argentina RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 126 Argentina RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 127 Argentina RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 128 Middle East & Africa RNA editing market, by country, 2021 - 2033 (USD Million)
  • Table 129 Middle East & Africa RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 130 Middle East & Africa RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 131 Middle East & Africa RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 132 Middle East & Africa RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 133 Middle East & Africa RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 134 Saudi Arabia RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 135 Saudi Arabia RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 136 Saudi Arabia RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 137 Saudi Arabia RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 138 Saudi Arabia RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 139 South Africa RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 140 South Africa RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 141 South Africa RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 142 South Africa RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 143 South Africa RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 144 UAE RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 145 UAE RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 146 UAE RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 147 UAE RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 148 UAE RNA editing market, by end use, 2021 - 2033 (USD Million)
  • Table 149 Kuwait RNA editing market, by offering, 2021 - 2033 (USD Million)
  • Table 150 Kuwait RNA editing market, by technology, 2021 - 2033 (USD Million)
  • Table 151 Kuwait RNA editing market, by delivery modality, 2021 - 2033 (USD Million)
  • Table 152 Kuwait RNA editing market, by application, 2021 - 2033 (USD Million)
  • Table 153 Kuwait RNA editing market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 RNA Editing Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 RNA Editing Market driver analysis
  • Fig. 12 RNA Editing Market restraint analysis
  • Fig. 13 RNA Editing Market: Porter's five forces analysis
  • Fig. 14 RNA Editing Market: PESTLE analysis
  • Fig. 15 RNA Editing Market: Offering outlook and key takeaways
  • Fig. 16 RNA Editing Market: Offering market share analysis
  • Fig. 17 Therapeutics development & licensing market, 2021 - 2033 (USD Million)
  • Fig. 18 Research tools & reagents market, 2021 - 2033 (USD Million)
  • Fig. 19 Services market, 2021 - 2033 (USD Million)
  • Fig. 20 RNA Editing Market: Technology outlook and key takeaways
  • Fig. 21 RNA Editing Market: Technology market share analysis
  • Fig. 22 ADAR-mediated (A-to-I) editing market, 2021 - 2033 (USD Million)
  • Fig. 23 APOBEC-mediated (C-to-U) editing market, 2021 - 2033 (USD Million)
  • Fig. 24 Others (exon editing, pseudouridylation) market, 2021 - 2033 (USD Million)
  • Fig. 25 RNA Editing Market: Delivery modality outlook and key takeaways
  • Fig. 26 RNA Editing Market: Delivery modality market share analysis
  • Fig. 27 Oligonucleotide-based market, 2021 - 2033 (USD Million)
  • Fig. 28 AAV-delivered market, 2021 - 2033 (USD Million)
  • Fig. 29 LNP-delivered market, 2021 - 2033 (USD Million)
  • Fig. 30 Others market, 2021 - 2033 (USD Million)
  • Fig. 31 RNA Editing Market: Application outlook and key takeaways
  • Fig. 32 RNA Editing Market: Application market share analysis
  • Fig. 33 Rare genetic disorders market, 2021 - 2033 (USD Million)
  • Fig. 34 Neurological disorders market, 2021 - 2033 (USD Million)
  • Fig. 35 Oncology market, 2021 - 2033 (USD Million)
  • Fig. 36 Liver diseases market, 2021 - 2033 (USD Million)
  • Fig. 37 Cardiometabolic diseases market, 2021 - 2033 (USD Million)
  • Fig. 38 Others market, 2021 - 2033 (USD Million)
  • Fig. 39 RNA Editing Market: End use outlook and key takeaways
  • Fig. 40 RNA Editing Market: End use market share analysis
  • Fig. 41 Pharmaceutical & biotechnology companies market, 2021 - 2033 (USD Million)
  • Fig. 42 Academic & research institutes market, 2021 - 2033 (USD Million)
  • Fig. 43 CROs & CDMOs market, 2021 - 2033 (USD Million)
  • Fig. 44 Regional marketplace: Key takeaways
  • Fig. 45 North America RNA editing market, by country, 2021 - 2033 (USD Million)
  • Fig. 46 U.S. RNA editing market, 2021 - 2033 (USD Million)
  • Fig. 47 Canada RNA editing market, 2021 - 2033 (USD Million)
  • Fig. 48 Mexico RNA editing market, 2021 - 2033 (USD Million)
  • Fig. 49 Europe RNA editing market, by country, 2021 - 2033 (USD Million)
  • Fig. 50 Germany RNA editing market, 2021 - 2033 (USD Million)
  • Fig. 51 UK RNA editing market, 2021 - 2033 (USD Million)
  • Fig. 52 France RNA editing market, 2021 - 2033 (USD Million)
  • Fig. 53 Italy RNA editing market, 2021 - 2033 (USD Million)
  • Fig. 54 Spain RNA editing market, 2021 - 2033 (USD Million)
  • Fig. 55 Denmark RNA editing market, 2021 - 2033 (USD Million)
  • Fig. 56 Sweden RNA editing market, 2021 - 2033 (USD Million)
  • Fig. 57 Norway RNA editing market, 2021 - 2033 (USD Million)
  • Fig. 58 Asia Pacific RNA editing market, by country, 2021 - 2033 (USD Million)
  • Fig. 59 Japan RNA editing market, 2021 - 2033 (USD Million)
  • Fig. 60 China RNA editing market, 2021 - 2033 (USD Million)
  • Fig. 61 India RNA editing market, 2021 - 2033 (USD Million)
  • Fig. 62 Australia RNA editing market, 2021 - 2033 (USD Million)
  • Fig. 63 South Korea RNA editing market, 2021 - 2033 (USD Million)
  • Fig. 64 Thailand RNA editing market, 2021 - 2033 (USD Million)
  • Fig. 65 Latin America RNA editing market, by country, 2021 - 2033 (USD Million)
  • Fig. 66 Brazil RNA editing market, 2021 - 2033 (USD Million)
  • Fig. 67 Argentina RNA editing market, 2021 - 2033 (USD Million)
  • Fig. 68 MEA RNA editing market, by country, 2021 - 2033 (USD Million)
  • Fig. 69 Saudi Arabia RNA editing market, 2021 - 2033 (USD Million)
  • Fig. 70 South Africa RNA editing market, 2021 - 2033 (USD Million)
  • Fig. 71 UAE RNA editing market, 2021 - 2033 (USD Million)
  • Fig. 72 Kuwait RNA editing market, 2021 - 2033 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!